Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ZG-801 Phase III Trial - Randomized, Double-blind, Placebo-controlled Trial of ZG-801 in Patients With Hyperkalemia -

NCT04955678 is registered in ClinicalTrials.gov with Zeria Pharmaceutical as lead sponsor.

NCT NCT04955678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04955678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ZG-801 Phase III Trial - Randomized, Double-blind, Placebo-controlled Trial of ZG-801 in Patients With Hyperkalemia -
Lead sponsor
Zeria Pharmaceutical
Phase
Phase 3
Overall status
Completed
Start date
August 3, 2021
Completion date
March 13, 2023
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia